Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Biological & Pharmaceutical Bulletin|January 16, 2015
Efficacy and safety of human placental extract for alcoholic and nonalcoholic steatohepatitis: an open-label, randomized, comparative studyJin Young Choi, Kyeheui Lee, Seung Min Lee, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 12, 2020
Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis BSoon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, et al.Clinical and Molecular Hepatology|May 23, 2016
A case of portal hypertension by presumed as plexiform neurofibroma at the hepatic hilumKyung Han Lee, Sun Hong Yoo, Gi Tark Noh, et al.Journal of Hepatology|July 25, 2012
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinomaMyeong Jun Song, Ho Jong Chun, Do Seon Song, et al.The Korean Journal of Hepatology|February 8, 2012
Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolizationPil Soo Sung, Si Hyun Bae, Jeong Won Jang, et al.Gut|November 2, 2019
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysisSung Won Lee, Jung Hyun Kwon, Hae Lim Lee, et al.Journal of Clinical Medicine|December 29, 2020
A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCCJaejun Lee, Pil Soo Sung, Hyun Yang, et al.The American Journal of Gastroenterology|March 18, 2021
Prediction of Hepatocellular Carcinoma by On-Therapy Response of Noninvasive Fibrosis Markers in Chronic Hepatitis BHeechul Nam, Sung Won Lee, Jung Hyun Kwon, et al.Trials|March 28, 2023
Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trialSoon Kyu Lee, Hyun Yang, Jung Hyun Kwon, et al.Journal of Liver Cancer|June 29, 2023
Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter studySun Hong Yoo, Soon Sun Kim, Sang Gyune Kim, et al.Pageof 4